Defining the Molecular and Physiological Mechanisms of Pancreatic Islet Cell Dysfunction Which Lead to Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

328

Participants

Timeline

Start Date

March 4, 2015

Primary Completion Date

March 31, 2019

Study Completion Date

August 31, 2019

Conditions
Diabetes Mellitus
Interventions
OTHER

Glucose-Potentiated Arginine-Induced Insulin Secretion

Intravenous catheters are inserted into antecubital veins in both arms. One arm is used for infusion of glucose/amino acid (Arginine). The other arm is used for intermittent sampling.

Trial Locations (2)

EX2 5DW

University of Exeter, Exeter

OX3 7LE

University of Oxford, Oxford

All Listed Sponsors
collaborator

University of Exeter

OTHER

collaborator

University of Oxford

OTHER

collaborator

Oxford University Hospitals NHS Trust

OTHER

lead

Royal Devon and Exeter NHS Foundation Trust

OTHER

NCT02505308 - Defining the Molecular and Physiological Mechanisms of Pancreatic Islet Cell Dysfunction Which Lead to Type 2 Diabetes | Biotech Hunter | Biotech Hunter